Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment. | Front Oncol | 2022 | 36003772 | PubTator, text mining | PubMed |
| Advances in Computational Polypharmacology. | Mol Inform | 2022 | 36002382 | PubTator, text mining | PubMed |
| Developmental RNA-Seq transcriptomics of haploid germ cells and spermatozoa uncovers novel pathways associated with teleost spermiogenesis. | Sci Rep | 2022 | 35986060 | PubTator, text mining | PubMed |
| Serological biomarkers in autoimmune GFAP astrocytopathy. | Front Immunol | 2022 | 35983033 | PubTator, text mining | PubMed |
| Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer. | Aging (Albany NY) | 2022 | 35969182 | PubTator, text mining | PubMed |
| GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells. | Front Immunol | 2022 | 35967396 | PubTator, text mining | PubMed |
| In the literature: July 2022. | ESMO Open | 2022 | 35961192 | PubTator, text mining | PubMed |
| Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation. | Int J Mol Sci | 2022 | 35955805 | PubTator, text mining | PubMed |
| Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis. | Clin Exp Immunol | 2022 | 35951003 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma. | Front Oncol | 2022 | 35936716 | PubTator, text mining | PubMed |
| Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate. | Front Immunol | 2022 | 35935962 | PubTator, text mining | PubMed |
| Anti-inflammatory clearance of amyloid-β by a chimeric Gas6 fusion protein. | Nat Med | 2022 | 35927581 | PubTator, text mining | PubMed |
| Cabozantinib combination therapy for the treatment of solid tumors: a systematic review. | Ther Adv Med Oncol | 2022 | 35923927 | PubTator, text mining | PubMed |
| Screening of cell-virus, cell-cell, gene-gene crosstalk among animal kingdom at single cell resolution. | Clin Transl Med | 2022 | 35917402 | PubTator, text mining | PubMed |
| The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends? | Front Mol Biosci | 2022 | 35911967 | PubTator, text mining | PubMed |
| Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer. | Front Immunol | 2022 | 35911763 | PubTator, text mining | PubMed |
| The role of macrophage TAM receptor family in the acute-to-chronic progression of liver disease: From friend to foe? | Liver Int | 2022 | 35900248 | PubTator, text mining | PubMed |
| The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. | Int J Mol Sci | 2022 | 35897651 | PubTator, text mining | PubMed |
| Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies. | Stem Cell Rev Rep | 2022 | 35896860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=32